- Home
- SBSI vs EYPT Comparison
SBSI vs EYPT Comparison
Compare SBSI & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBSI
- EYPT
- Stock Information
- Founded
- SBSI 1960
- EYPT 1987
- Country
- SBSI United States
- EYPT United States
- Employees
- SBSI N/A
- EYPT N/A
- Industry
- SBSI Major Banks
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- SBSI Finance
- EYPT Industrials
- Exchange
- SBSI Nasdaq
- EYPT Nasdaq
- Market Cap
- SBSI 920.2M
- EYPT 741.0M
- IPO Year
- SBSI N/A
- EYPT 2005
- Fundamental
- Price
- SBSI $31.31
- EYPT $11.83
- Analyst Decision
- SBSI Hold
- EYPT Strong Buy
- Analyst Count
- SBSI 3
- EYPT 7
- Target Price
- SBSI $35.00
- EYPT $24.29
- AVG Volume (30 Days)
- SBSI 113.6K
- EYPT 657.3K
- Earning Date
- SBSI 07-25-2025
- EYPT 08-06-2025
- Dividend Yield
- SBSI 4.60%
- EYPT N/A
- EPS Growth
- SBSI 4.30
- EYPT N/A
- EPS
- SBSI 2.81
- EYPT N/A
- Revenue
- SBSI $254,956,000.00
- EYPT $51,898,000.00
- Revenue This Year
- SBSI $10.88
- EYPT N/A
- Revenue Next Year
- SBSI $5.60
- EYPT N/A
- P/E Ratio
- SBSI $11.13
- EYPT N/A
- Revenue Growth
- SBSI 6.01
- EYPT 2.99
- 52 Week Low
- SBSI $25.85
- EYPT $3.91
- 52 Week High
- SBSI $38.00
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- SBSI 61.38
- EYPT 67.14
- Support Level
- SBSI $29.54
- EYPT $10.84
- Resistance Level
- SBSI $30.44
- EYPT $11.50
- Average True Range (ATR)
- SBSI 0.60
- EYPT 0.76
- MACD
- SBSI 0.14
- EYPT 0.10
- Stochastic Oscillator
- SBSI 100.00
- EYPT 88.61
About SBSI Southside Bancshares Inc.
Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.